AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
ENPH, NVDA, VMW, SEDG, PNR, F, GM, BIIB
TCRX, MIND, ATLO, LLY, PFMT, REAL, ROCC, QMCO, UNH, XFLT
Damien ConoverSector Director